{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:16Z","timestamp":1740120076530,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12185-020-02968-w","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T12:03:20Z","timestamp":1597233800000},"page":"780-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series"],"prefix":"10.1007","volume":"112","author":[{"given":"Yuichi","family":"Sumii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-5460","authenticated-orcid":false,"given":"Noboru","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Makita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sogabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Imajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Meguri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisakazu","family":"Nishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuharu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,12]]},"reference":[{"key":"2968_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2017."},{"key":"2968_CR2","first-page":"307","volume":"2005","author":"C Thieblemont","year":"2005","unstructured":"Thieblemont C. Clinical presentation and management of marginal zone lymphomas. ASH Educ Program Book. 2005;2005:307\u201313.","journal-title":"ASH Educ Program Book."},{"key":"2968_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3324\/haematol.2012.083386","volume":"98","author":"M van den Brand","year":"2013","unstructured":"van den Brand M, van Krieken JH. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica. 2013;98:1003\u201313.","journal-title":"Haematologica"},{"key":"2968_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/PAS.0b013e31816148ad","volume":"32","author":"W Cheuk","year":"2008","unstructured":"Cheuk W, Yuen HK, Chan AC, Shih LY, Kuo TT, Ma MW, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159\u201367.","journal-title":"Am J Surg Pathol"},{"key":"2968_CR5","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archophthalmol.2010.45","volume":"128","author":"T Kubota","year":"2010","unstructured":"Kubota T, Moritani S, Katayama M, Terasaki H. Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder. Arch Ophthalmol. 2010;128:577\u201384.","journal-title":"Arch Ophthalmol"},{"key":"2968_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1440-1827.2010.02524.x","volume":"60","author":"Y Sato","year":"2010","unstructured":"Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int. 2010;60:247\u201358.","journal-title":"Pathol Int"},{"key":"2968_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1440-1827.2008.02257.x","volume":"58","author":"Y Sato","year":"2008","unstructured":"Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465\u201370.","journal-title":"Pathol Int"},{"key":"2968_CR8","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s10384-011-0003-9","volume":"55","author":"T Oyama","year":"2011","unstructured":"Oyama T, Takizawa J, Nakamura N, Aoki S, Aizawa Y, Abe H. Multifocal mucosa-associated lymphoid tissue lymphoma associated with IgG4-related disease: a case report. Jpn J Ophthalmol. 2011;55:304\u20136.","journal-title":"Jpn J Ophthalmol"},{"key":"2968_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3960\/jslrt.52.51","volume":"52","author":"Y Sato","year":"2012","unstructured":"Sato Y, Ohshima K, Takata K, Huang X, Cui W, Ohno K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52:51\u20135.","journal-title":"J Clin Exp Hematop."},{"key":"2968_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12185-008-0170-8","volume":"88","author":"Y Sato","year":"2008","unstructured":"Sato Y, Takata K, Ichimura K, Tanaka T, Morito T, Tamura M, et al. IgG4-producing marginal zone B-cell lymphoma. Int J Hematol. 2008;88:428\u201333.","journal-title":"Int J Hematol"},{"key":"2968_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/modpathol.2010.206","volume":"24","author":"G Venkataraman","year":"2011","unstructured":"Venkataraman G, Rizzo KA, Chavez JJ, Streubel B, Raffeld M, Jaffe ES, et al. Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases. Mod Pathol. 2011;24:355\u201366.","journal-title":"Mod Pathol"},{"key":"2968_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","volume":"26","author":"I Brenner","year":"2013","unstructured":"Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol. 2013;26:1568\u201376.","journal-title":"Mod Pathol"},{"key":"2968_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00795-016-0139-2","volume":"49","author":"T Igawa","year":"2016","unstructured":"Igawa T, Hayashi T, Ishiguro K, Maruyama Y, Takeuchi M, Takata K, et al. IgG4-producing lymphoma arising in a patient with IgG4-related disease. Med Mol Morphol. 2016;49:243\u20139.","journal-title":"Med Mol Morphol."},{"key":"2968_CR14","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"2968_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"2968_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Tabeya T, Suzuki C, Naishiro Y, Ishigami K, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012;22:414\u20138.","journal-title":"Mod Rheumatol"},{"key":"2968_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95:802\u20136.","journal-title":"Blood"},{"key":"2968_CR18","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489\u201395.","journal-title":"Blood"},{"key":"2968_CR19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0016-5085(91)90063-Q","volume":"101","author":"SB Cogliatti","year":"1991","unstructured":"Cogliatti SB, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991;101:1159\u201370.","journal-title":"Gastroenterology"},{"key":"2968_CR20","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/S0360-3016(01)02714-6","volume":"52","author":"S Hitchcock","year":"2002","unstructured":"Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM, et al. Treatment outcome of mucosa-associated lymphoid tissue\/marginal zone non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys. 2002;52:1058\u201366.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2968_CR21","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1200\/JCO.1998.16.5.1916","volume":"16","author":"NR Schechter","year":"1998","unstructured":"Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916\u201321.","journal-title":"J Clin Oncol"},{"key":"2968_CR22","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0360-3016(01)01549-8","volume":"50","author":"RW Tsang","year":"2001","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys. 2001;50:1258\u201364.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2968_CR23","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","volume":"102","author":"A Conconi","year":"2003","unstructured":"Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741\u20135.","journal-title":"Blood"},{"key":"2968_CR24","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23:1979\u201383.","journal-title":"J Clin Oncol"},{"key":"2968_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361\u201392.","journal-title":"Blood"},{"key":"2968_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/annonc\/mdt507","volume":"25","author":"AH Meyer","year":"2014","unstructured":"Meyer AH, Stroux A, Lerch K, Eucker J, Eitle J, Hohloch K, et al. Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma. Ann Oncol. 2014;25:210\u20135.","journal-title":"Ann Oncol"},{"key":"2968_CR27","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1200\/JCO.1999.17.8.2486","volume":"17","author":"BN Nathwani","year":"1999","unstructured":"Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR, et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin\u2019s Lymphoma Classification Project. J Clin Oncol. 1999;17:2486\u201392.","journal-title":"J Clin Oncol"},{"key":"2968_CR28","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","volume":"24","author":"H Ghesquieres","year":"2006","unstructured":"Ghesquieres H, Berger F, Felman P, Callet-Bauchu E, Bryon PA, Traverse-Glehen A, et al. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis. J Clin Oncol. 2006;24:5234\u201341.","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-020-02968-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-020-02968-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:11:13Z","timestamp":1628727073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-020-02968-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2968"],"URL":"https:\/\/doi.org\/10.1007\/s12185-020-02968-w","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2020,8,12]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}